Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study-Reference-Cited by-同舟云学术

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

Published:2023-08-04 Issue:11 Volume:64 Page:1847-1856
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dachs Laura Rosiñol¹,Gaisán Carmen Montes²,Bustamante Gabriela³,López Sebastián Garzón⁴,García Esther González⁵,Persona Ernesto Pérez⁶⁷,González-Calle Verónica⁸⁹¹⁰,Auzmendi Maialen Sirvent¹¹,Pérez José Maria Arguiñano¹²,González Montes Yolanda¹³,Ríos Tamayo Rafael¹⁴,de Miguel Llorente Dunia¹⁵,Bernal Luis Palomera¹⁶,Mayol Antonia Sampol¹⁷,Caro Carmen Couto¹⁸,Grande Marta¹⁹²⁰,Fernández-Nistal Alonso¹⁹,Naves Andrea¹⁹,Miguel Enrique M. Ocio San²

Affiliation:

1. Hospital Clinic, Barcelona, Barcelona, Spain

2. Hospital Universitario Marqués de Valdecilla (IDIVAL). Universidad de Cantabria. Santander, Spain

3. ICO Institut Català d’Oncologia, L’Hospitalet de Llobregat, Spain

4. Hospital de Jerez, Jerez de la Frontera, Spain

5. Hospital Cabueñes, Gijón, Spain

6. Instituto de Investigación Sanitaria Bioaraba, Vitoria-Gasteiz, Spain

7. Osakidetza. Hospital Universitario de Álava. Vitoria-Gasteiz, Spain

8. Hospital Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain

9. Centro de Investigación Biomédica en Red (CIBERONC), Spain

10. Instituto Universitario de Biología Molecular y Celular del Cáncer - IBMCC (USAL-CSIC), Salamanca, Spain

11. Hospital Donostia, Donostia, Spain

12. Complejo Hospitalario de Navarra, Pamplona, Spain

13. ICO Institut Català d’Oncologia-Trueta, Girona, Spain

14. Hospital Universitario Puerta de Hierro, Majadahonda, Spain

15. Hospital Universitario Guadalajara, Guadalajara, Spain

16. Hospital Lozano Blesa, Zaragoza, Spain

17. Hospital Son Espases, Palma, Spain

18. Hospital Valme, Sevilla, Spain

19. Takeda Farmacéutica España, Madrid, Spain

20. Universidad de Alcalá, Madrid, Spain

Funder

Takeda Farmacéutica España

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2240922

Reference36 articles.

1. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management

2. Multiple Myeloma Research Foundation - MMRF [Internet]. [cited 2019 Jun 11]. Available from: https://themmrf.org/.

3. Multiple Myeloma

4. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group